ArticlePharmaceutical science advances2025

Physiologically based pharmacokinetic (PBPK) modeling of drug-drug interactions between suraxavir marboxil and CYP3A4 inhibitors: Quantitative prediction of pharmacokinetic effects on active metabolite GP1707D07.

Lan Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.